Compositions and methods for treating type 1 and type 2 diabetes and related disorders
US10912800B2 · kind B2 · utility
4Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 2016 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Mar 27, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features compositions comprising in vitro generated beta cells capable of glucose-stimulated insulin secretion, methods of inducing beta cell maturation from embryonic or induced pluripotent stem cell-derived beta-like cells, and methods of using in vitro generated beta cells for the treatment of type 1 diabetes, type 2 diabetes, or a related disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.